Advanced Oncotherapy – Director Dealing

Advanced Oncotherapy announces that Michael Sinclair, Executive Chairman of the Company, had yesterday purchased an option over 30 million ordinary shares of 1 penny each in the Company from Brahma AG at a cost of £300,000. The Option vests immediately, expires two years from today’s date and has an exercise price of 10p per Ordinary Share.

Following the above transaction, Michael Sinclair’s interest in the Company is as follows:

Ordinary Shares:                                                68,079,757

Options over Ordinary Shares:                           65,800,000

Warrants over Ordinary Shares:                         28,500,000

For further information contact: